HeartFlow Analysis vs Cardiomo
AI Verdict
Choose HeartFlow Analysis if…
Choose HeartFlow Analysis if you need a non-invasive, highly accurate diagnostic tool to assess the functional impact of coronary artery blockages. It's ideal for patients with suspected coronary artery disease, especially those with symptoms like chest pain or inconclusive stress tests, to determine if an intervention like stenting or bypass surgery is necessary.
View HeartFlow Analysis →Choose Cardiomo if…
Choose Cardiomo if you require continuous, remote monitoring of heart health and vital signs for early detection of cardiovascular diseases and timely alerts. This medical-grade wearable is well-suited for individuals, particularly those aged 45 and above with existing heart issues, who need 24/7 tracking and immediate notifications to users, caregivers, and medical professionals in case of critical events.
View Cardiomo →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | HeartFlow Analysis | Cardiomo |
|---|---|---|
| Pricing | Contact vendor for pricing | Contact for pricing |
| Deployment | Cloud-based (AWS) | Cloud-based with wearable device and mobile app |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | Unknown |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
CardiomoCardiomo offers a wearable patch and mobile app for continuous, real-time monitoring, which is generally considered user-friendly for patients, especially the elderly, and provides immediate alerts to caregivers. HeartFlow Analysis, while non-invasive, requires a CT scan and subsequent analysis, making it a less continuous and more clinician-driven process from the patient's perspective.
Clinical Value
HeartFlow AnalysisHeartFlow Analysis has extensive clinical validation with over 200 studies assessing over 365,000 patients, demonstrating high diagnostic accuracy and impact on clinical decision-making, including guiding revascularization procedures. Cardiomo, while offering continuous monitoring and early disease detection, has fewer publicly available large-scale clinical validation studies, with most being small-scale and short-duration.
Pricing & Value
HeartFlow AnalysisHeartFlow Analysis has established Category I CPT codes for its services, is covered by Medicare and most U.S. commercial payers, and has publicly available CMS payment rates, indicating clear reimbursement pathways and recognized value within the healthcare system. Cardiomo's current pricing details are not publicly available, and while it previously offered a device with a monthly subscription, its reimbursement landscape appears less established for broad clinical adoption.
Enterprise Readiness
HeartFlow AnalysisHeartFlow Analysis is deployed as a cloud-based solution (AWS) and has been adopted by over 1,800 institutions globally, indicating robust infrastructure and proven integration capabilities within healthcare systems. Cardiomo is also cloud-based with a mobile app, but its enterprise adoption and integration capabilities with large healthcare systems are less extensively documented in the provided information.
Innovation
TieBoth tools demonstrate significant innovation in their respective domains. HeartFlow leverages AI and computational fluid dynamics to create personalized 3D models and FFRct analysis from CT scans, offering a non-invasive approach to diagnose CAD. Cardiomo innovates with a medical-grade wearable patch for continuous, real-time remote monitoring and AI-powered disease detection, addressing a different but equally important aspect of cardiac care.
Support & Docs
HeartFlow AnalysisHeartFlow provides comprehensive support including billing and reimbursement assistance, technology integration with PACS/EMR, educational materials for clinicians and patients, and peer-to-peer education. While Cardiomo offers real-time alerts and data for doctors and caregivers, specific details on structured support, documentation, and integration services for healthcare providers are not as extensively outlined.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | HeartFlow Analysis | Cardiomo |
|---|---|---|
| Name | HeartFlow Analysis | Cardiomo |
| Company | HeartFlow | Cardiomo, Inc. |
| Tagline | Decisive Coronary Care | A medical-grade wearable device that monitors vital signs and uses an AI engine to detect cardiovascular diseases and provide life-saving alerts. |
| Description | HeartFlow Analysis is a commercial-stage medical technology company providing software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD) by creating personalized 3D models of patients' coronary arteries from standard CT scans. | Cardiomo offers a medical-grade wearable device and an AI-powered platform for continuous and remote heart health monitoring, designed to detect cardiovascular diseases and provide timely alerts to users and caregivers. |
| Key Features | AI-powered 3D modeling of coronary arteries, Fractional Flow Reserve derived from CT (FFRct) analysis, Plaque Analysis (quantification and characterization), Roadmapu2122 Analysis for CCTA reading, Non-invasive diagnostic assessment, Personalized patient insights, Computational Fluid Dynamics (CFD) for blood flow simulation, High diagnostic accuracy | Medical-grade wearable patch, Continuous vital sign monitoring (ECG, heart rate, respiration, skin temperature), AI-powered disease detection (arrhythmias, cardiovascular events), Real-time alerts and notifications, Mobile application (Android and iOS), HIPAA-compliant cloud analytics, Fall detection, Long battery life (up to 7-10 days) |
Videos
Demos, reviews, and walkthroughs featuring HeartFlow Analysis and Cardiomo.
Frequently Asked Questions
More Comparisons
More matchups featuring HeartFlow Analysis or Cardiomo
Backers
Who funded each tool's parent company.